, Singapore
328 views

Which companies will be the hardest hit by China’s COVID-19 resurgence?

UOB Kay Hian said there is a total of eight that will be most affected.

Eight Singapore companies are at risk amidst a resurgence of COVID-19 in China, UOB Kay Hian said.

In a report, the analyst named China Sunsine, Jiutian Chemical, Sasseur REIT, Trans-China Automotive, Yangzijiang, Innotek, Dairy Farm, and Nanofilm as the companies which would likely see their "2022 profitability come under pressure should the country’s zero-COVID policy result in business stoppage or interruption.”

According to UOB Kay Hian, these companies derive over 70% of their revenue from China, whilst the first five also have 100% exposure to the country.

Despite the risk, the analyst has yet to change their earnings forecast for these companies, adding that the impact of the resurgence “at present would be mild.”

Meanwhile, the analyst said large-caps such as Ascott Trust, Capitaland Investment, Genting Singapore, Mapletree Industrial Trust, OCBC, Singtel, Sembcorp Industries, Thai Beverage, Venture Corp, Wilmar, and Yangzijiang all have minimal exposure to China, thus safe to invest in.

Looking ahead, UOB Kay Hian forecast a 10.7 year-on-year full-year earnings growth for the combined large-cap and REITs sectors, excluding the aviation sector.

Join Singapore Business Review community

Follow the link for more news on

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.